Chiaffarelli R, Cruz P, Cotton J, Kelm T, Lee S, Ghaderian M
JACS Au. 2025; 5(2):779-790.
PMID: 40017765
PMC: 11862947.
DOI: 10.1021/jacsau.4c01020.
Storchmannova K, Balouch M, Juracka J, Stepanek F, Berka K
Mol Pharm. 2025; 22(3):1293-1304.
PMID: 39977255
PMC: 11881145.
DOI: 10.1021/acs.molpharmaceut.4c00975.
Simonova A, Balouch M, Stepanek F, Krizek T
Anal Bioanal Chem. 2025; .
PMID: 39939418
DOI: 10.1007/s00216-025-05783-6.
Crncevic D, Krce L, Brkljaca Z, Cvitkovic M, Babic Brcic S, coz-Rakovac R
RSC Adv. 2025; 15(2):1490-1506.
PMID: 39822568
PMC: 11737066.
DOI: 10.1039/d4ra07975b.
Ruczynski J, Prochera K, Kazmierczak N, Kosznik-Kwasnicka K, Piechowicz L, Mucha P
Molecules. 2024; 29(23).
PMID: 39683678
PMC: 11643744.
DOI: 10.3390/molecules29235519.
Elucidating Antibiotic Permeation through the Outer Membrane: Insights from Molecular Dynamics.
Deylami J, Chng S, Yong E
J Chem Inf Model. 2024; 64(21):8310-8321.
PMID: 39480067
PMC: 11558678.
DOI: 10.1021/acs.jcim.4c01249.
Tracing the path of Quorum sensing molecules in cystic fibrosis mucus in a biomimetic in vitro permeability platform.
Garbero O, Sardelli L, Butnarasu C, Frasca E, Medana C, Dal Bello F
Sci Rep. 2024; 14(1):25907.
PMID: 39472521
PMC: 11522324.
DOI: 10.1038/s41598-024-77375-w.
In Vitro Evaluation of Pharmacokinetic Properties of Selected Dual COX-2 and 5-LOX Inhibitors.
Boskovic J, Dobricic V, Savic J, Rupar J, Aleksic M, Markovic B
Pharmaceuticals (Basel). 2024; 17(10).
PMID: 39458971
PMC: 11510591.
DOI: 10.3390/ph17101329.
A Novel Prodrug Strategy Based on Reversibly Degradable Guanidine Imides for High Oral Bioavailability and Prolonged Pharmacokinetics of Broad-Spectrum Anti-influenza Agents.
Jung Y, Ahn S, An T, Cha H, Kim M, Cheon H
ACS Cent Sci. 2024; 10(8):1573-1584.
PMID: 39220698
PMC: 11363325.
DOI: 10.1021/acscentsci.4c00548.
The backbone constitution drives passive permeability independent of side chains in depsipeptide and peptide macrocycles inspired by -verticilide.
Thorpe M, Smith A, Blackwell D, Hopkins C, Knollmann B, Akers W
Chem Sci. 2024; .
PMID: 39211739
PMC: 11348715.
DOI: 10.1039/d4sc02758b.
Improving the Accuracy of Permeability Data to Gain Predictive Power: Assessing Sources of Variability in Assays Using Cell Monolayers.
Pires C, Moreno M
Membranes (Basel). 2024; 14(7).
PMID: 39057665
PMC: 11278619.
DOI: 10.3390/membranes14070157.
Recent advances in methods for quantifying the cell penetration of macromolecules.
Batistatou N, Kritzer J
Curr Opin Chem Biol. 2024; 81:102501.
PMID: 39024686
PMC: 11323051.
DOI: 10.1016/j.cbpa.2024.102501.
Determination of bisphosphonate properties in terms of bioavailability, bone affinity, and cytotoxicity.
Zielinska M, Pacholak A, Burlaga N, Chmielewska E, Voelkel A, Kaczorek E
Pharmacol Rep. 2024; 76(5):1160-1173.
PMID: 39007946
PMC: 11387443.
DOI: 10.1007/s43440-024-00624-2.
New Skin-Relevant Cell Coculture Model With Stratum Corneum-Like Layer.
Quijas G, Lewinska A, Lukaszewicz M, Bojanowski K
Biomed Res Int. 2024; 2024:1041392.
PMID: 38933176
PMC: 11208096.
DOI: 10.1155/2024/1041392.
Amine-containing donepezil analogues as potent acetylcholinesterase inhibitors with increased polarity.
Kaltbeitzel J, Kersten C, Wich P
RSC Med Chem. 2024; 15(6):2037-2044.
PMID: 38911155
PMC: 11187544.
DOI: 10.1039/d3md00635b.
Structural Modifications of Covalent Cathepsin S Inhibitors: Impact on Affinity, Selectivity, and Permeability.
Meta M, Zimmer C, Fuchs N, Zecher M, Lahu A, Schirmeister T
ACS Med Chem Lett. 2024; 15(6):837-844.
PMID: 38894911
PMC: 11181490.
DOI: 10.1021/acsmedchemlett.4c00050.
Substitution-Induced Mechanistic Switching in SAr-Warheads for Cysteine Proteases.
Zimmer C, Brauer J, Ferenc D, Meyr J, Muller P, Rader H
Molecules. 2024; 29(11).
PMID: 38893535
PMC: 11173422.
DOI: 10.3390/molecules29112660.
Endogenous Opioid Activity as the Mechanism of Action for Mitragyna speciosa (Kratom): The Current State of the Evidence.
Bowe A, Kerr P
Adv Neurobiol. 2024; 35:287-313.
PMID: 38874729
DOI: 10.1007/978-3-031-45493-6_15.
Liposomal Copermeation Assay Reveals Unexpected Membrane Interactions of Commonly Prescribed Drugs.
Odehnalova K, Balouch M, Storchmannova K, Petrova E, Konefal M, Zadrazil A
Mol Pharm. 2024; 21(6):2673-2683.
PMID: 38682796
PMC: 11151206.
DOI: 10.1021/acs.molpharmaceut.3c00766.
Orally Bioavailable Proteolysis-Targeting Chimeras: An Innovative Approach in the Golden Era of Discovering Small-Molecule Cancer Drugs.
Rej R, Rao Allu S, Roy J, Acharyya R, Kiran I, Addepalli Y
Pharmaceuticals (Basel). 2024; 17(4).
PMID: 38675453
PMC: 11054475.
DOI: 10.3390/ph17040494.
